istock-855160904casarsaguru
CasarsaGuru / iStockphoto.com
30 July 2018Biotechnology

CJEU gene-editing decision ‘could stifle’ innovation in Europe

A ruling handed down last week by the Court of Justice of the European Union (CJEU) could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
26 July 2018   Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday.

More on this story

Biotechnology
26 July 2018   Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday.

More on this story

Biotechnology
26 July 2018   Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday.